CN118685373A - High-temperature-resistant laccase mutant and preparation and application thereof - Google Patents
High-temperature-resistant laccase mutant and preparation and application thereof Download PDFInfo
- Publication number
- CN118685373A CN118685373A CN202411171011.6A CN202411171011A CN118685373A CN 118685373 A CN118685373 A CN 118685373A CN 202411171011 A CN202411171011 A CN 202411171011A CN 118685373 A CN118685373 A CN 118685373A
- Authority
- CN
- China
- Prior art keywords
- laccase
- mutant
- lac
- temperature
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010029541 Laccase Proteins 0.000 title claims abstract description 113
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 239000013612 plasmid Substances 0.000 claims description 17
- 239000010902 straw Substances 0.000 claims description 16
- 240000008042 Zea mays Species 0.000 claims description 13
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 13
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 13
- 235000005822 corn Nutrition 0.000 claims description 13
- 241000609240 Ambelania acida Species 0.000 claims description 11
- 239000010905 bagasse Substances 0.000 claims description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 230000000593 degrading effect Effects 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000035772 mutation Effects 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 32
- 108090000790 Enzymes Proteins 0.000 abstract description 32
- 241000193744 Bacillus amyloliquefaciens Species 0.000 abstract description 21
- 244000063299 Bacillus subtilis Species 0.000 abstract description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract description 9
- 241001506991 Komagataella phaffii GS115 Species 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 abstract description 5
- 241000672609 Escherichia coli BL21 Species 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 33
- 229940088598 enzyme Drugs 0.000 description 31
- 229920005610 lignin Polymers 0.000 description 28
- 238000000855 fermentation Methods 0.000 description 19
- 230000004151 fermentation Effects 0.000 description 19
- 238000006731 degradation reaction Methods 0.000 description 17
- 230000015556 catabolic process Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000002609 medium Substances 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241001052560 Thallis Species 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 229920002488 Hemicellulose Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 239000007836 KH2PO4 Substances 0.000 description 3
- 241000235058 Komagataella pastoris Species 0.000 description 3
- 102000043368 Multicopper oxidase Human genes 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 3
- 108700020788 multicopper oxidase Proteins 0.000 description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- JMFRWRFFLBVWSI-NSCUHMNNSA-N coniferol Chemical compound COC1=CC(\C=C\CO)=CC=C1O JMFRWRFFLBVWSI-NSCUHMNNSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- -1 na 2HPO44 Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000010907 stover Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101100165177 Caenorhabditis elegans bath-15 gene Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical group [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 241000302587 Macrocybe gigantea Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000895811 Myza Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241001138370 Pleurotus pulmonarius Species 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 244000044283 Toxicodendron succedaneum Species 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229940119526 coniferyl alcohol Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
Abstract
The invention belongs to the technical field of genetic engineering of enzymes, and particularly relates to a high-temperature-resistant laccase mutant, and preparation and application thereof. The laccase gene (lac) from bacillus amyloliquefaciens (bacillus amyloliquefaciens) is expressed in escherichia coli BL 21; the error-prone PCR technology is utilized to mutate the gene lac, and the ABTS is utilized to screen the mutant, so that the mutant T262F/T387L with improved thermal stability is selected, and the expression preparation in bacillus subtilis WB600, bacillus amyloliquefaciens CGMCC No.11218 and pichia pastoris GS115 is realized.
Description
Technical Field
The invention belongs to the technical field of genetic engineering of enzymes, and particularly relates to a high-temperature-resistant laccase mutant, and preparation and application thereof.
Background
Lignocellulose straw is a potential and exploitable biomass resource, the components of the straw mainly comprise cellulose, hemicellulose and lignin, covalent bonding of the lignin and the hemicellulose and the cellulose prevents effective degradation of the lignin, and lignin removal is a precondition for utilizing the cellulose and the hemicellulose. The processes applied to the current industrial field for removing lignin are a strong alkali high-temperature pulping technology for cellulose utilization and a strong acid high-temperature xylose (or furfural) technology for hemicellulose utilization, and all the processes have the problem of prohibiting or limiting development caused by environmental pollution.
The biological enzyme method is used for replacing strong acid and alkali technology to degrade lignin, and is the most effective means for solving pollution and increasing benefit. However, due to the complexity of chemical bonds between the components of lignocellulosic straw, there are significant obstacles to degrading lignin using a single enzyme with specific properties. The lignin degradation is possible by adopting the combination of enzymes with different functions as the complex enzyme under the same scene, and the lignin degradation enzyme with specific functional attributes, such as laccase, can not function under the conditions (such as temperature, pH, enzyme activity and the like) applied to the specific scene in the complex enzyme due to the natural enzymatic attributes, and the aim is realized by laccase mutants, genes, engineering bacteria and preparation thereof.
Laccase, belonging to the blue multicopper oxidase (MCOs) family, is the largest subfamily of MCOs, is widely distributed in various organisms, and has multiple functions. Laccase typically comprises four copper atoms, one T1Cu, one T2Cu and two T3Cu. Laccase can catalyze the single electron oxidation of phenolic compounds and derivatives thereof to form corresponding reactive free radicals or benzoquinone intermediates, O 2 is a final electron acceptor, H 2 O generated is the only byproduct, and the free radical intermediates are spontaneously coupled with each other outside the catalytic center of laccase to generate oligomers and polymers. Oxidation of laccase in lignin degradation results in reduced methyl content in residual lignin structure, increased conjugated carbonyl, increased carbonyl and ester groups, and improved lignin degradability and availability. This suggests that laccase can be an environmentally friendly, widely used "green catalyst" both in vivo and in vitro. Laccase has wide application in industrial fields.
Laccase is a ubiquitous enzyme that is widely distributed in nature and is commonly produced by plants, insects, fungi and bacteria. Laccases of lacquer tree origin were the beginning of laccase research. Laccase can react with coniferyl alcohol and the like in plants as substrates to generate lignin. Can also thoroughly degrade lignin. In addition, laccase is involved in the protective action of plants and invasion of pathogenic bacteria. Less research is done on laccases of insect origin. At present, insects which have laccase activity are found to be myza sativa, tobacco astromoth, green head fly, mosquito, locust and the like. Fungal source laccase is a hot spot for research because white rot fungi laccase can degrade lignin. Until now research on laccase enzymes of fungal origin has not been stopped, such as Pleurotus pulmonarius, tricholoma giganteum-derived laccase enzymes. Laccase is found in bacteria later than fungal laccase, and previously reported bacterial sources of laccase are Bacillus sphaericus, azospirllum lipoferum and Alternomonas. Around bacterial laccases, mainly bacillus-derived laccases are being studied. Most of fungus-derived laccase is unstable under conditions of high temperature, high alkali and the like, and most of metal ions and inhibitors have obvious inhibition effect on the fungus laccase. Compared with fungal laccase, bacterial laccase can act at high temperature, in a wider pH range and at high salt concentration, and compared with other bacterial laccase, bacillus laccase has more excellent alkali resistance and thermal stability and is less influenced by metal ions. In the industrial degradation process of straw, high temperature assistance is often required. Therefore, the stability of the laccase is further improved on the basis of the wild bacillus laccase, and the laccase is beneficial to industrial application.
Therefore, in the invention, laccase mutant genes with improved thermal stability are obtained by carrying out mutation on laccase genes from bacillus amyloliquefaciens (bacillus amyloliquefaciens). And then, the high temperature resistant mutant laccase is prepared by using a bacillus and pichia pastoris expression system.
Disclosure of Invention
Based on the problem of laccase high-temperature application scene, in order to obtain laccase with improved thermal stability, the existing property of the laccase needs to be further modified, and the invention aims to provide a high-temperature-resistant laccase mutant. Expressing a laccase gene (lac) derived from bacillus amyloliquefaciens (bacillus amyloliquefaciens) in escherichia coli BL 21; the error-prone PCR technology is utilized to mutate the gene lac, and the ABTS is utilized to screen the mutant, so that the mutant with improved thermal stability is selected, and the expression preparation in bacillus subtilis WB600, bacillus amyloliquefaciens CGMCC No.11218 and pichia pastoris GS115 is realized.
The technical route for achieving the purpose of the invention is summarized as follows:
The laccase gene LAC from bacillus amyloliquefaciens (bacillus amyloliquefaciens) is mutated, and a escherichia coli expression system is used for screening to obtain mutant T262F/T387L and encoding gene lacm1, so that the half life of the mutant T262F/T387L at 80 ℃ is improved to 172% of that of wild Laccase (LAC). The efficient preparation of the optimal mutant laccase T262F/T387L is realized by using bacillus subtilis WB600, bacillus amyloliquefaciens CGMCC No.11218 and pichia pastoris GS 115.
One of the technical schemes provided by the invention is a laccase mutant, wherein the mutant is obtained by mutating a wild laccase shown in SEQ ID NO.1 and comprises T262F and T387L, and is named as a T262F/T387L mutant;
Further, the amino acid sequence of the T262F/T387L mutant is shown as SEQ ID NO. 3;
furthermore, the nucleotide sequence of the coding gene lacm of the T262F/T387L mutant is shown as SEQ ID NO. 4.
The second technical scheme provided by the invention is a recombinant plasmid or recombinant strain containing the mutant coding gene;
further, the adopted expression vector is pET-28a (+), and the host is escherichia coli, bacillus subtilis, bacillus amyloliquefaciens or pichia pastoris;
still further, the host cell is E.coli BL21;
Further, the host cell is bacillus subtilis WB600, or the host cell is bacillus amyloliquefaciens CGMCC No.11218, or the host cell is pichia pastoris GS115;
preferably, the recombinant strain is obtained by connecting a mutant coding gene with an expression vector pET-28a (+) and then expressing the mutant coding gene in host escherichia coli.
The third technical scheme provided by the invention is the application of the recombinant plasmid or recombinant strain in the laccase mutant in the first technical scheme of production.
The fourth technical scheme provided by the invention is the application of the laccase mutant in the first technical scheme, in particular to the application in degradation of lignocellulose;
further, the method is applied to degrading straw or bagasse;
further, the method is applied to degradation of corn straw, rice straw or wheat straw.
The following definitions are employed in the present invention:
1. nomenclature of amino acids and DNA nucleic acid sequences
Using the accepted IUPAC nomenclature for amino acid residues, in single letter or three letter codes. The DNA nucleic acid sequence uses accepted IUPAC nomenclature.
2. Identification of laccase mutants
"Original amino acid+position+substituted amino acid" is used to denote the mutated amino acid in the LAC mutant. As T262F, the amino acid at position 262 is replaced by Phe by Thr of the wild-type LAC, the numbering of the position corresponding to the amino acid sequence numbering of the mature peptide of the wild-type LAC in SEQ ID NO. 1.
In the present invention, LAC represents wild-type laccase, T262F/T387L represents laccase mutant, lower case italics LAC represents the gene encoding wild-type laccase LAC, lower case italics lacm1 represents the gene encoding mutant T262F/T387L, and specific information is as follows.
Advantageous effects
The invention uses error-prone PCR technology to mutate LAC wild type to obtain mutant T262F/T387L with improved thermal stability at 80 ℃ compared with wild type, and the half life of the mutant T262F/T387L at 80 ℃ is improved to 172% of wild type Laccase (LAC).
Drawings
FIG. 1 is an electrophoresis chart of PCR amplification of wild type laccase
Wherein: m is DNA MARKER, lane 1 is laccase gene lac.
FIG. 2 shows the cleavage map of pET-lac plasmid
Wherein: m is DNA MARKER, and 1 is pET-lac subjected to NcoI and XhoI double digestion.
FIG. 3 shows the change of enzyme activity over time at 80℃for wild-type and mutant T262F/T387L laccase.
Detailed Description
The technical contents of the present invention will be further described with reference to examples, but the present invention is not limited to these examples, and the scope of the present invention is not limited to the following examples.
The partial solutions and culture mediums used in the examples of the present invention are as follows:
lysis buffer (mM): tris 20, naCl 500, dithiothreitol 1, imidazole 20.
Wash buffer (mM): tris 20, naCl 500, dithiothreitol 1, imidazole 100.
ElutionBuffer (mM): tris 20, naCl 500, dithiothreitol 1, imidazole 500.
LB medium (g/L): yeast extract 5.0, tryptone 10.0, naCl 10.0, the balance being water. 2% agar was added to the solid medium.
BMGY Medium (g/L): peptone 20.0, yeast extract 10.0, YNB 13.4, 4X 10 -5% biotin, 10% 1:1 mmol/L potassium phosphate buffer (pH 6.0), 0.5% glycerol.
BMMY medium (g/L): peptone 20.0, yeast extract 10.0, YNB 13.4, 4X 10 -5% biotin, 10% 1:1 mmol/L potassium phosphate buffer (pH 6.0), 0.5% methanol.
Fermentation medium (g/L): corn flour 64, bean cake flour 40, 2.7 amylase, 4 Na 2HPO4,0.3 KH2PO4 and the balance of water; preserving heat at 90 ℃ for 30min and sterilizing at 121 ℃ for 20min.
In the invention, the mature peptide sequence of the wild laccase LAC is shown as SEQ ID NO.1 :MALEKFADELPIIETLKPQKTSNGSTYYEVTMKECFHKLHRDLPPTRLWGYNGLFPGPTIDVNQDENVYIKWMNDLPDKHFLPVDHTIHHSEGGHQEPDVKTVVHLHGGATPPDSDGYPEAWFTRDFKEKGPYFEKEVYHYPNKQRGALLWYHDHAMAITRLNVYAGLAGMYIIRERKEKQLKLPAGEYDVPLMIMDRTLNDDGSLFYPSGPDNPSETLPNPSIVPFLCGNTILVNGKAWPYMEVEPRTYRFRILNASNTRTFSLSLNNGGRFIQIGSDGGLLPRSVKTQSISLAPAERYDVLIDFSAFDGEHIILTNGTGCGGDVNPDTDANVMQFRVTKPLKGEDTSRKPKYLSAMPDMTSKRIHNIRTLKLTNTQDKYGRPVLTLNNKRWHDPVTEAPRLGSTEIWSIINPTRGTHPIHLHLVSFQVLDRRPFDLERYNKFGDIVYTGPAVPPPPSEKGWKDTVQAHSGEVIRIAATFAPYSGRYVWHCHILEHEDYDMMRPMDVTDKQ.
In the invention, the mature peptide sequence of the T262F/T387L mutant is shown in SEQ ID NO. 3:
MALEKFADELPIIETLKPQKTSNGSTYYEVTMKECFHKLHRDLPPTRLWGYNGLFPGPTIDVNQDENVYIKWMNDLPDKHFLPVDHTIHHSEGGHQEPDVKTVVHLHGGATPPDSDGYPEAWFTRDFKEKGPYFEKEVYHYPNKQRGALLWYHDHAMAITRLNVYAGLAGMYIIRERKEKQLKLPAGEYDVPLMIMDRTLNDDGSLFYPSGPDNPSETLPNPSIVPFLCGNTILVNGKAWPYMEVEPRTYRFRILNASNTRFFSLSLNNGGRFIQIGSDGGLLPRSVKTQSISLAPAERYDVLIDFSAFDGEHIILTNGTGCGGDVNPDTDANVMQFRVTKPLKGEDTSRKPKYLSAMPDMTSKRIHNIRTLKLTNTQDKYGRPVLLLNNKRWHDPVTEAPRLGSTEIWSIINPTRGTHPIHLHLVSFQVLDRRPFDLERYNKFGDIVYTGPAVPPPPSEKGWKDTVQAHSGEVIRIAATFAPYSGRYVWHCHILEHEDYDMMRPMDVTDKQ.
The invention will be further illustrated by the following examples.
EXAMPLE 1 obtaining wild-type laccase Gene
1. Genomic DNA of Bacillus amyloliquefaciens (bacillus amyloliquefaciens) TCCC 111465 was extracted using a kit (OMEGA: bacterial DNA Kit) as follows:
(1) Strains were inoculated onto LB solid plates with an inoculating loop and incubated overnight at 37 ℃.
(2) Single colonies were picked from plates of cultured cells and inoculated into liquid test tube medium, shake-cultured at 37℃and 220 r/min overnight.
(3) 3 ML-5 mL bacteria solution was placed in sterilized EP tube, centrifuged at 12000 r/min for 2 min, and the supernatant was discarded.
(4) 200 Mu L of sterile water is added into an EP tube to resuspend the thalli, 50 mu L of lysozyme is added, and the mixture is blown and sucked uniformly, and the temperature is kept at 37 ℃ for 20 min.
(5) 100. Mu.L of BTL buffer and 20. Mu.L of proteinase K were added to the EP tube, mixed by vortexing, incubated at 55℃40 min, and mixed by vortexing every 20: 20 min.
(6) Add 5. Mu.L RNase and mix upside down several times and leave 10 min at room temperature.
(7) Centrifuge 2min at 12000 r/min, remove undigested fractions, transfer supernatant to a new EP tube, add 220. Mu.L BDL buffer,65℃water bath 15 min.
(8) 220 Mu L absolute ethyl alcohol is added, and the mixture is blown and sucked uniformly.
(9) Transferring the liquid in the EP pipe into a recovery column, standing for 1 min, centrifuging for 1 min at 12000 r/min, pouring the filtrate into the recovery column again, repeating for two times, and pouring out the waste liquid.
(10) 500. Mu.L of HBC buffer was added, and the mixture was centrifuged at 12000 r/min for 1:1 min, and the filtrate was discarded.
(11) 700 Mu L DNA wash buffer was added, left stand for 1 min, centrifuged at 12000 r/min for 1 min, and the filtrate was discarded.
(12) Adding 500 mu L DNA wash buffer, standing for 1 min, centrifuging at 12000 r/min for 1 min, and discarding the filtrate.
(13) 12000 R/min air-separation 2 min, discard the waste tube and put the recovery column into a new EP tube.
(14) The mixture is placed in a 55 ℃ metal bath for drying 10min.
(15) 50. Mu.L of sterile water at 55℃was added, the mixture was allowed to stand at room temperature for 5min, centrifuged at 12000 r/min for 2 min, the recovery column was discarded, and the liquid in the EP tube was the genome.
2. The genome of the extracted bacillus amyloliquefaciens is taken as a template, a pair of primers are designed at the upstream and downstream of an ORF frame, and restriction enzyme cutting sites NcoI and XhoI are respectively introduced, and the amplification primers of laccase gene lac of the invention are as follows:
The upstream primer P1:
5’- GAAGGAGATATACCATGGGCATGGCACTGGAAAAATTTG -3’
downstream primer P2:
5’- TGGTGGTGGTGGTGCTCGAGCTGCTTATCCGTGACGTCC -3’
P1 and P2 are used as an upstream primer and a downstream primer, and the genome of the bacillus amyloliquefaciens laccase is used as a template for amplification.
The reaction system for amplification is as follows:
The amplification procedure was: pre-denaturation at 98 ℃ of 30 s; denaturation at 98℃for 10 s, annealing at 54℃for 20 s, extension at 72℃for 8 s, reaction for 30 cycles; the extension is 10 min at 72 ℃. The PCR amplified product is subjected to 0.8% agarose gel electrophoresis to obtain 1536 bp bands (figure 1), a small amount of DNA recovery kit is used for recovering the PCR product to obtain the wild type laccase gene lac (SEQ ID NO. 2), the pET-28a (+) plasmid is subjected to double digestion by restriction enzymes NcoI and XhoI, the recovered lac is subjected to homologous recombination connection with a carrier pET carrier to obtain a recombinant plasmid pET-lac, the digestion verification is shown in figure 2, and the recombinant plasmid pET-lac is converted into escherichia coli BL21 and is named as recombinant strain BL21/pET-lac.
Example 2LAC Activity and temperature stability determination
ABTS assay LAC enzyme activity assay method:
(1) 200 mu L of citric acid-disodium hydrogen phosphate buffer solution (50 mM and containing 5 mM Cu 2+) with pH of 5.5 is taken in a 96-well ELISA plate, and the temperature is kept in a water bath at 80 ℃ for 1 min;
(2) Adding 10 mu L of LAC/LACM diluted to a proper concentration, uniformly mixing, and putting into 80 ℃ water bath again for heat preservation of 1 min;
(3) Then, 30 mu L of ABTS (50 mM) is added for blowing and sucking, and the mixture is uniformly mixed, and reacted in a water bath at a constant temperature of 80 ℃ for 10min, after the reaction starts and ends, OD values after the reaction starts and ends are recorded under 420 nm.
Calculating the enzyme activity:
Wherein: Δod = OD end-OD initial;
v1 represents the total volume ([ mu ] L) of the reaction system;
Δt represents the reaction time (min);
V2 adding the volume (μl) of enzyme solution;
Epsilon represents the molar absorption coefficient of the product at 420 nm, 36 mM -1cm-1;
d represents the inner diameter/optical path thickness (cm) of the 96-well microplate.
Enzyme specific activity (U/mg) =enzyme activity/protein concentration.
Temperature stability measurement of LAC was placed in a buffer solution at pH 7.0 and incubated at 80℃for different times, samples were taken at regular time, residual enzyme activity was measured at pH 5.0 and 80℃after incubation was completed, and the residual enzyme activity was calculated by taking the enzyme activity without incubation as 100%, and the enzyme activity change curve was drawn to further calculate half-life.
EXAMPLE 3LAC mutant construction and screening
1. Construction of mutant libraries
Error-prone PCR: error-prone PCR was performed using the wild-type coding gene lac as a template, and the reaction system was as follows:
Note that: the above reagents were obtained from Takara, takara Bio Inc.
After the system is completed, error-prone PCR reaction is carried out, and the program is set as follows:
a. Pre-denaturation at 95℃5 min;
b. denaturation: 95. 30℃ s;
c. Annealing: 56. 45℃ s;
d. extension: 72. 50 ℃ s;
e.b-d reactions were carried out for 35 cycles;
f. extension at 72℃of 10min.
After the PCR reaction is finished, the PCR amplification product is subjected to 0.8% agarose gel electrophoresis, and the PCR product is recovered by using a small amount of DNA recovery kit, so that different laccase mutant genes lacm are obtained. Recombinant plasmid pET-lacm is constructed through enzyme digestion and connection, and then the recombinant plasmid pET-lacm is transformed into escherichia coli BL21 to obtain recombinant strain BL21/pET-lacm.
2. Mutant screening
(1) Adding 2 mL sterilized LB culture medium into a 96-well plate, adding 2 [ mu ] L Kan resistance (action concentration 50 [ mu ] g/mL), adding different mutant single colonies, and culturing overnight in a shaking table at 37 ℃ with the contrast being wild type;
(2) Transferring the bacterial liquid to a new 24-well plate according to the inoculation amount of 2%, adding 1 mL sterilized LB (containing Kan resistance) into each well, carrying out shaking culture at 37 ℃ and 600 r/min for 3 h (culturing until the OD600 is 0.6-0.8), adding 0.5 mM IPTG final concentration into each well, and inducing overnight culture at 16 ℃ under a shaking table;
(3) Using a hole plate centrifuge to collect thalli, centrifuging for 15 min at 5000 r/min, pouring out supernatant, blowing and sucking the mixed thalli by using a buffer solution with pH of 7.0, respectively collecting the thalli into a 2mL centrifuge tube, and crushing cells. After the crushing is completed, centrifugally collecting the crushed supernatant, dividing the crushed supernatant into two parts, wherein one part is used for measuring the enzyme activities of different mutants in a water bath kettle at 80 ℃ according to the step 1 of the example 2; the other part was incubated at 80℃for 30 min and the thermostability of the different mutants was determined according to step 2 of example 2;
(4) The mutant strain is obtained by selecting a mutant transformant in which the absorbance of the crushed supernatant catalytic ABTS is higher than that of the wild type strain at 420 nm and the absorbance of the catalytic ABTS is still higher than that of the wild type strain at 420 nm after the temperature is maintained at 80 ℃ for 30 min, sequencing the mutant transformant to obtain a mutant gene lacm (shown as SEQ ID NO. 4), and finally obtaining a mutant T262F/T387L (shown as SEQ ID NO. 3) with activity and stability higher than those of the wild type strain through preliminary screening, wherein the transformant containing the mutant strain is named as a recombinant strain BL21/pET-lacm1.
EXAMPLE 4 expression purification and enzyme Activity determination of WT and T262F/T387L
1. Induction expression of recombinant strains
(1) On an LB plate, respectively picking a single colony of BL21/pET-lacm1 and BL21/pET-lac, inoculating in a 5mL LB test tube (containing 50 mug/mLKan), and placing in a shaking table at 37 ℃ for shake culture for 10 h;
(2) Transferring the recombinant bacterial liquid into a 250 mL LB culture medium (final concentration is 50 mug/mL Kan), and placing the culture medium in a shaking table at 37 ℃ for shake culture for 2-2.5 h;
(3) Adding 125 mu L of IPTG (final concentration is 0.5 mmol/L), and performing induced culture on the mixture in a 16 ℃ shaking table to obtain 16-20 h;
(4) And (3) purifying the fermentation liquor to prepare wild laccase and laccase mutants.
2. Ni column purification of recombinant proteins
(1) Breaking thallus
The fermentation broth was collected using a centrifuge cup, 10000 rpm, centrifuged 15 min, the supernatant was removed, 20mL Lysis buffer cells were sucked by blowing and the cells were disrupted by ultrasonic waves, the cell walls were destroyed, and the intracellular proteins were released.
After the completion of the disruption, the bacterial liquid was poured into a 50 mL centrifuge tube, and centrifuged at 12000rpm at 4℃for 30 min, and the disrupted supernatant was collected.
(2) WT and T262F/T387L binding to Nickel column
A. Before the nickel column purification process, add the appropriate amount of ddH 2 O to the purification column and add double column volume of Lysis buffer to equilibrate the resin;
b. mixing the balanced resin and thallus supernatant, placing in magnetic stirrer, combining at speed of 80-100 r/min with 1:1 h, and maintaining low temperature (4deg.C).
(3) Protein purification
A. adding the combined liquid into the purification column for 2-3 times in a chromatography cabinet;
b. after the binding solution is completely filtered out, 10 mL Wash buffer is added to elute the hybrid protein bound with the resin;
c. Finally, adding 10 mL pre-cooled absorption Buffer into the purification column, eluting all target proteins combined with the resin, and collecting filtrate;
d. all the eluate was transferred to an ultrafiltration centrifuge tube, and when the solution remained in the centrifuge and ultrafiltration tube by 1 mL, 50mM of pre-chilled Tris-HCl buffer solution with pH of 7.0 was added, and the displacement was repeated twice. Purified WT and T262F/T387L proteins were obtained.
The specific activity was determined according to example 2, step 1, and the final calculated specific activities of wild-type LAC and mutant T262F/T387L were as follows:
The temperature stability was measured according to example 2, step 2, to obtain thermal stability at 80 ℃ (i.e. the enzyme activity of WT and T262F/T387L mutants was measured according to the method of example 2, step 2, after incubation at 80 ℃ for different times, the enzyme activity change curve was plotted, the enzyme activity change curve is shown in fig. 3), and finally the half-lives of wild-type LAC and mutant were calculated as follows:
EXAMPLE 5 expression and preparation of laccase mutants in Bacillus subtilis
The laccase mutant T262F/T387L coding gene lacm and the wild laccase coding gene lac are respectively connected with an expression plasmid pLY-3 to obtain new recombinant plasmids pLY-3-lacm1 and pLY-3-lac;
The recombinant plasmids are respectively transferred into bacillus subtilis WB600, and the mutant recombinant bacterium WB600/pLY-3-lacm1 and the wild laccase recombinant bacterium WB600/pLY-3-lac are obtained through the screening of the resistance of the kanamycin (Kan) and the enzyme digestion verification.
Recombinant strains WB600/pLY-3-lacm1 and WB600/pLY-3-lac were inoculated into fermentation medium (containing kanamycin, 50. Mu.g/mL) of 5 mL, cultured overnight at 37℃at 220 r/min, transferred into fresh fermentation medium (containing kanamycin, 50. Mu.g/mL) of 50 mL at an inoculum size of 2%, continuously cultured at 37℃at 220 r/min for 48 h (fermentation medium (g/L): corn meal 64, soybean meal 40), added with 2.7 amylase, na 2HPO44, KH2PO4 0.3.3, the balance being water, incubated at 90℃for 30min and sterilized at 121℃for 20 min.
The enzyme activity of laccase obtained by fermentation of Bacillus subtilis was determined by the ATBS method in example 2 (enzyme activity was determined by centrifuging the fermentation broth to obtain the supernatant). The wild type enzyme activity in the bacillus subtilis is 1172.3U/mL, and the fermentation enzyme activity of T262F/T387L is 1452.1U/mL.
EXAMPLE 6 expression and preparation of laccase mutant in recombinant strain of Bacillus amyloliquefaciens
The laccase mutant T262F/T387L coding gene lacm and the wild laccase coding gene lac are respectively connected with an expression plasmid pLY-3 to obtain new recombinant plasmids pLY-3-lacm1 and pLY-3-lac;
The recombinant plasmid is respectively transferred into bacillus amyloliquefaciens CGMCC No.11218, and is subjected to resistance screening of kananamycin (Kan) and enzyme digestion verification to obtain mutant recombinant bacterium CGMCC No.11218/pLY-3-lacm1 and wild laccase recombinant bacterium CGMCC No.11218/pLY-3-lac.
Recombinant strains CGMCC No.11218/pLY-3-lacm1 and CGMCC No.11218/pLY-3-lac are respectively inoculated into a fermentation culture medium (containing kanamycin and 50 mu g/mL) of 5mL, cultured overnight at 37 ℃,220 r/min, transferred into a fresh fermentation culture medium (containing kanamycin and 50 mu g/mL) of 50mL according to the inoculum size of 2%, continuously cultured at 37 ℃,220 r/min and 48 h (fermentation culture medium (g/L): corn powder 64, bean cake powder 40, 2.7 amylase, na 2HPO44, KH2PO4 0.3 and the balance water are added, and the temperature is kept at 90 ℃ for 30min and then sterilized at 121 ℃ for 20 min.
Laccase activity obtained by fermentation of Bacillus amyloliquefaciens was determined using the ATBS method of example 2 (enzyme activity was determined by centrifugation of the fermentation broth from supernatant). The wild type enzyme activity of the bacillus amyloliquefaciens is 2358.3U/mL, and the fermentation enzyme activity of the T262F/T387L is 2912.8U/mL.
Example 7 expression and preparation of laccase mutant in Pichia pastoris GS115 recombinant strain
The laccase mutant T262F/T387L coding gene lacm and the wild laccase coding gene lac are respectively connected with an expression plasmid pPIC9K to obtain new recombinant plasmids pPIC9K-lacm1 and pPIC9K-lac; ;
Linearizing recombinant plasmids pPIC9K-lacm1 and pPIC9K-lac by using restriction endonuclease SalI, respectively electrically transferring the linearized recombinant plasmids into Pichia pastoris GS115, screening the resistance of the kanamicin, and performing enzyme digestion verification to obtain mutant recombinant bacteria GS115/pPIC9K-lacm1 and wild laccase recombinant bacteria GS115/pPIC9K-lac.
(1) Single colonies of recombinant expression strains GS115/pPIC9K-lacm and GS115/pPIC9K-lac were picked and inoculated into 5 mL YPD tubes containing 50. Mu.g/mL Kan, cultured at 30℃and 200 r/min for 24 h;
(2) Inoculating 1 mL bacterial liquid into BMGY enrichment medium, culturing at 30deg.C and 220 r/min for 16-19 h;
(3) Collecting bacterial liquid in the BMGY culture medium by using a 50 mL centrifuge tube, and centrifugally collecting bacterial bodies; adding 20 mL BMMY culture medium to resuspend the thalli, centrifuging to collect the thalli, and repeating the process once; the bacteria were resuspended in 10 mL BMMY medium and transferred to BMMY medium with a pipette, and methanol was added at a final concentration of 0.5% every 12: 12 h, and cultured for 6 d.
The activity of laccase obtained by fermentation of Pichia pastoris was determined using the ATBS method in example 2 (enzyme activity was determined by centrifugation of the fermentation broth from supernatant). In Pichia pastoris GS115, the fermentation activity of laccase is 1674.2U/mL, and the fermentation activity of T262F/T387L is 2031.6U/mL.
Example 8 application of laccase mutant in degrading corn stalk and bagasse
Pre-treatment of corn stover and bagasse the corn stover and bagasse were derived from a local enterprise in Jiangsu China. Firstly, deionized water is used for cleaning to remove dirt on the surface, then the surface is placed in a constant-temperature drying box at 60 ℃ for drying so that the moisture content is below 2%, the dried raw materials are crushed by a crusher and filtered by a 40-mesh screen to ensure that the raw materials become uniform powder, and finally, the uniform powder is placed at normal temperature for subsequent use.
2. Laccase degradation lignin
Respectively adding the wild laccase and the mutant laccase T262F/T387L of the invention into treated corn stalks and bagasse which are respectively taken as samples to be degraded, and adopting a system of 20 mL: taking 1 g to-be-degraded sample in a 50 mL centrifuge tube, adding 50U of WT/mutant laccase, adding 5mM Cu 2+ citric acid-disodium hydrogen phosphate buffer solution with pH of 5.0, supplementing to 20 mL, and carrying out shaking table reaction at 50 ℃ in 150 r/min water bath for 6 h.
Lignin degradation rates after laccase wild type and mutant T262F/T387L treatment were determined. The method comprises the following steps:
(1) Extracting the treated corn stalks and bagasse with benzene/alcohol to obtain 8 h, and drying until the corn stalks and bagasse are absolute dried for later use;
(2) 0.3 g was weighed, added to 72% sulfuric acid of 3 mL, and stirred until the materials were thoroughly mixed. Mixing, and placing in 30deg.C water bath for heat preservation of 60 min;
(3) Adding 84 mL deionized water to dilute to 4%, placing into a 121 ℃ sterilizing pot, taking out after 45: 45 min, vacuum filtering by using a G3 (weighing, marked as m 0) sand core funnel, measuring the absorbance value of acidolysis solution at 205: 205 nm by using 50: 50 mL filtrate, and calculating the content of acid-soluble lignin, wherein the measuring method is GB/10337-89 measurement of acid-soluble lignin in papermaking raw materials and paper pulp;
The filtered residue was washed to neutrality with hot deionized water, dried in an oven at 105 ℃, and weighed for recording (m 1). Drying, transferring into a resistance furnace, and burning at 575 ℃ to 4 h. The content of acid-insoluble lignin was calculated by taking out and cooling to room temperature and then weighing and recording (m 2). The final calculated lignin degradation rate is as follows:
1. degradation result of lignin in corn straw
The lignin degradation rate of the mutant after treatment is 23.7%, and the lignin degradation rate of the WT after treatment is 17.2%.
2. Degradation results of lignin in bagasse
The lignin degradation rate of the mutant T262F/T387L is 22.5 percent after being treated, and the lignin degradation rate of the mutant T262F/T387L is 15.3 percent after being treated by the WT.
The results show that the lignin degradation rate of the mutant on the corn straw and the bagasse is higher than that of the WT when the straw and the bagasse are treated by laccase.
The above examples merely represent a few embodiments of the present invention, which are described in more detail and are not to be construed as limiting the scope of the patent. It should be noted that, for a person skilled in the art, the above embodiments may also make several variations, combinations and improvements, without departing from the scope of the present patent. Therefore, the protection scope of the patent is subject to the claims.
Claims (8)
1. A laccase mutant is characterized in that the laccase mutant is obtained by carrying out T262F and T387L mutation on the basis of wild laccase shown in SEQ ID NO.1, and the amino acid sequence is shown in SEQ ID NO. 3.
2. A gene encoding the laccase mutant of claim 1.
3. The laccase mutant coding gene according to claim 2, wherein the nucleotide sequence is shown in SEQ ID NO. 4.
4. A recombinant plasmid or recombinant strain comprising the mutant encoding gene of claim 2.
5. Use of the recombinant plasmid or recombinant strain of claim 4 for the production of the laccase mutant of claim 1.
6. The use of a laccase mutant according to claim 1 or 2, characterized in that it is used for degrading lignocellulose.
7. The use according to claim 6, wherein the lignocellulose includes, but is not limited to, straw, bagasse.
8. The use of claim 7, wherein the straw includes, but is not limited to, corn straw, rice straw, and wheat straw.
Publications (1)
Publication Number | Publication Date |
---|---|
CN118685373A true CN118685373A (en) | 2024-09-24 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112646792B (en) | Low-temperature inulase exonuclease mutant MutA122 delta 5 with reduced thermal stability and application | |
CN111378585B (en) | Pichia pastoris mutant strain for expressing exogenous gene | |
CN109988714B (en) | Trichoderma reesei and application thereof | |
US20210123081A1 (en) | Recombinant strain expressing phospholipase d and application thereof | |
WO2021143696A1 (en) | Factor regulating protein expression efficiency of trichoderma reesei, and regulation method and use thereof | |
US20230242890A1 (en) | Phytase mutant | |
KR20220097451A (en) | Fungal strains comprising an improved protein productivity phenotype and methods thereof | |
US11613745B2 (en) | Recombinant oxalate decarboxylase expressed in filamentous fungi | |
CN109134630B (en) | Functional protein POX03016 and coding gene and application thereof | |
CN113980938B (en) | Method for obtaining high-yield high-stability heterologous beta-glucosidase | |
CN118685373A (en) | High-temperature-resistant laccase mutant and preparation and application thereof | |
EP2062967A1 (en) | Genetically engineered aspergillus | |
CN114426995B (en) | Method for improving yield of extracellular polysaccharide of cordyceps militaris by utilizing over-expressed hexokinase gene HK | |
CN114045293B (en) | Gene Aokap1 for improving kojic acid yield of aspergillus oryzae, method and application | |
CN111466511B (en) | Compositions containing a desepoxyprotease and methods of detoxification | |
CN118667778A (en) | High-temperature-resistant laccase mutant and engineering bacterium, preparation and application thereof | |
CN108949579B (en) | Thermoascus thermophilus gene expression system | |
US11371032B2 (en) | Beta glucosidase with high glucose tolerance, high thermal stability and broad PH activity spectrum | |
CN108251447B (en) | Plasmid capable of efficiently expressing lipase, construction method and application thereof | |
KR20090085379A (en) | Cellulase protein derived from bacillus amyloliquefaciens dl-3 and transformed escherichia coli dl-3 strain thereof | |
CN117925549A (en) | High-temperature-resistant laccase mutant and gene, engineering bacterium, preparation method and application thereof | |
CN114836393B (en) | Mao Shuankong bacterium laccase gene and preparation method and application of recombinant laccase thereof | |
CN117511891A (en) | Pichia pastoris engineering strain for high laccase production and application thereof | |
CN113388532B (en) | Recombinant trichoderma reesei for producing asparaginase and construction method and application thereof | |
CN114958853B (en) | Low-sugar response inducible promoter derived from aspergillus niger, method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication |